{
    "clinical_study": {
        "@rank": "83975", 
        "acronym": "ROQ_NUTRIFLORE", 
        "arm_group": [
            {
                "arm_group_label": "NUTRIOSE", 
                "arm_group_type": "Experimental", 
                "description": "group of volunteers fed with NUTRIOSE"
            }, 
            {
                "arm_group_label": "GLUCIDEX", 
                "arm_group_type": "Active Comparator", 
                "description": "gruop of volunteers fed with GLUCIDEX"
            }
        ], 
        "brief_summary": {
            "textblock": "NUTRIOSE is a food ingredient defined as a carbohydrate polymer of vegetable origin (wheat\n      starch or corn) with a degree of polymerization \u2265 3 and chemically transformed. It is\n      soluble in aqueous solution, very poorly digested in the small intestine, it mostly reaches\n      the colon where it stimulates fermentation. AFSSA, in its opinion of July 30, 2007,\n      considers that this ingredient is a \"soluble dietary fiber.\" The objective of this research\n      is to determine, among healthy subjects, the effect of this dietary fiber on changes in gut\n      microbiota and digestive tolerance during a 28 days consumption. Microbiological analyzes\n      will be performed by RT-PCR. Digestive tolerance will be measured by the intelligence of a\n      questionnaire by volunteers."
        }, 
        "brief_title": "Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota.", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Microbiota", 
            "Dietary Fibers"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged  20 to 50 years,\n\n          -  BMI 18 to 25 kg/m2,\n\n          -  absence of known or scalable organic or psychiatric disease\n\n          -  no history of chronic gastrointestinal disease\n\n          -  having a bowel regularity (1-3 defecation per day, of normal consistency),\n\n          -  person without medication during the study (especially laxatives, anti diarrheal)\n             (except contraceptives in women)\n\n          -  having normal laboratory hepatic and renal tests (ASAT, ALAT, GGT, urea, creatinine)\n\n          -  no pregnant nor nursing women\n\n          -  covered by Social Security\n\n          -  negative serology for hepatitis B/C and HIV\n\n          -  who signed the informed consent form\n\n        Exclusion Criteria:\n\n          -  persons abusing drugs (laxatives, anti-diarrheal)\n\n          -  person who doesn't want to stop taking food supplements containing pre- or probiotics\n             during time of the study\n\n          -  person intolerant to gluten and / or allergic to wheat flour\n\n          -  person in vegetarian or vegan diet\n\n          -  Inclusion in another clinical study\n\n          -  subjects receiving over 4,500 Euros in the last 12 months (including the present\n             study)\n\n          -  subjects presenting risk of non-compliance in the opinion of the recruiting doctor."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897649", 
            "org_study_id": "ROQ_NUTRIFLORE10"
        }, 
        "intervention": [
            {
                "arm_group_label": "NUTRIOSE", 
                "description": "15g/day NUTRIOSE FB06", 
                "intervention_name": "NUTRIOSE FB06", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "GLUCIDEX", 
                "description": "15g/day GLUCIDEX 21", 
                "intervention_name": "GLUCIDEX 21", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "functional food", 
            "digestive tolerance", 
            "microbiota", 
            "bifidogenic effect"
        ], 
        "lastchanged_date": "July 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bobigny", 
                    "country": "France", 
                    "zip": "93009"
                }, 
                "name": "Hopital Avicenne- Centre de Recherche Sur Volontaires-Service de Gastroenterologie"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of 15g Daily Consumption of NUTRIOSE During 2 and 4 Weeks on Healthy Volunteers Microbiota and Digestive Tolerance.", 
        "overall_official": {
            "affiliation": "Centre de Recherche en Nutrition Humaine d'Ile-de-France", 
            "last_name": "Robert BENAMOUZIG, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Clostridium Perfringens rate in stool", 
            "safety_issue": "No", 
            "time_frame": "D0 ; D14 ; D28"
        }, 
        "reference": [
            {
                "PMID": "21164548", 
                "citation": "Li S, Guerin-Deremaux L, Pochat M, Wils D, Reifer C, Miller LE. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab. 2010 Dec;35(6):773-82. doi: 10.1139/H10-074."
            }, 
            {
                "PMID": "21591985", 
                "citation": "Guerin-Deremaux L, Li S, Pochat M, Wils D, Mubasher M, Reifer C, Miller LE. Effects of NUTRIOSE\u00ae dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int J Food Sci Nutr. 2011 Sep;62(6):628-35. doi: 10.3109/09637486.2011.569492. Epub 2011 May 19."
            }, 
            {
                "PMID": "16482066", 
                "citation": "Pasman W, Wils D, Saniez MH, Kardinaal A. Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men. Eur J Clin Nutr. 2006 Aug;60(8):1024-34. Epub 2006 Feb 15."
            }, 
            {
                "PMID": "15870317", 
                "citation": "Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005 May;71(5):2318-24."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897649"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "digestive tolerance", 
                "safety_issue": "No", 
                "time_frame": "J0 to J28 (every day)"
            }, 
            {
                "measure": "stool pH", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14; D28"
            }, 
            {
                "measure": "total stool flora", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Bacteroides rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Eubacterium rectal rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Clostridium coccoides rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Clostridium leptum rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Bifidobacteria rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Lactobacteria rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Streptococcus rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Enterococcus rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Bacteroidetes rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Actinobacteria rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14; D28"
            }, 
            {
                "measure": "Firmicutes rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "E. Coli rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Clostridium difficile rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Faecalibacterium prausnitzii rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Clostridium difficile typa A and B rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "E. Coli EIEC + EPEC (eae gene) rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Shigella + E. Coli EIEC (ipaH gene) rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Listeria Monocytogenes rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }, 
            {
                "measure": "Yersinia Enterocolitica rate in stool", 
                "safety_issue": "No", 
                "time_frame": "D0 ; D14 ; D28"
            }
        ], 
        "source": "Nealth Sarl", 
        "sponsors": {
            "collaborator": {
                "agency": "Roquette Freres", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Nealth Sarl", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}